RFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban Ars Technica Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to What are peptides? FDA may ease restrictions on unproven health fad LiveNOW from FOX When will the FDA reclassify BPC 157 to Category 1 Octagon AI An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica